Skip to content
healthcare.dev
Get a free key

Curosurf

NDC 10122-510, poractant alfa, suspension, from Chiesi USA, Inc..

Product NDC
10122-510
Status
Listed
Labeler
Chiesi USA, Inc.
Dosage form
SUSPENSION
Route
ENDOTRACHEAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA020744
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10122-510 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PORACTANT ALFA80 mg/mL

Pharmacologic classes

Alveolar Surface Tension Reduction [PE]; Surfactant Activity [MoA]; Surfactant [EPC]

Package NDCNDC-11Package
10122-510-01101220510011.5 mL in 1 VIAL, GLASS (10122-510-01)
10122-510-03101220510033 mL in 1 VIAL, GLASS (10122-510-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/99bef307-00bd-4379-9f45-ede1380e74d4

Use it

Look up 10122-510 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10122-510 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10122-510. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.